TYROBP/DAP12 Protein
Introduction <table class="infobox infobox-protein">Protein Name </td>Gene </td>UniProt ID </td>Molecular Weight </td>Subcellular Localization </td>Protein Family </td>
...
TYROBP/DAP12 Protein
Introduction <table class="infobox infobox-protein">Protein Name </td>Gene </td>UniProt ID </td>Molecular Weight </td>Subcellular Localization </td>Protein Family </td>
Tyrobp Dap12 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
TYROBP (DAP12) is a transmembrane signaling adaptor protein that associates with [TREM2](/proteins/trem2-protein) to regulate microglial function in the brain. It is a critical component of the innate immune signaling pathway in myeloid cells, particularly [microglia](/cell-types/microglia-neuroinflammation) in the central nervous system. [@rudy2001]
Overview
Structure DAP12 is a type I transmembrane protein with:
Short extracellular domain (10 amino acids) - minimal extracellular portionSingle transmembrane helix - contains charged residue for receptor associationCytoplasmic ITAM (Immunoreceptor Tyrosine-based Activation Motif) - YxxL/I motif that becomes phosphorylatedThe ITAM motif contains the sequence YxxL/I that, when phosphorylated, creates a docking site for SYK family kinases.
Molecular Mechanisms
Signal Transduction Cascade DAP12 transduces signals when associated with activating receptors:
Receptor-ligand interaction - [TREM2](/genes/trem2) binds to ligands ([Aβ](/proteins/amyloid-beta), lipids, apolipoproteins)ITAM phosphorylation - Src family kinases (Fyn, Lyn) phosphorylate ITAM tyrosinesSYK recruitment - Phosphorylated ITAM recruits SYK/ZAP70 family kinasesDownstream activation - SYK activates multiple signaling pathways:PI3K/Akt pathway → cell survival, metabolism
MAPK/ERK pathway → cell proliferation, differentiation
[NF-κB](/entities/nf-kb) pathway → inflammatory gene expression
PLC-γ pathway → calcium signaling, cytoskeletal reorganization
TREM2-DAP12 Complex
TREM2 and DAP12 form a functional signaling complex
DAP12 is constitutively associated with TREM2 in the membrane
Ligand binding to TREM2 triggers rapid ITAM phosphorylation
Normal Function DAP12 transduces signals when associated with activating receptors:
TREM2 (Triggering Receptor Expressed on Myeloid Cells 2)Other triggering receptors on myeloid cells including CLEC5A, CLECSF12Signaling through DAP12 regulates:
Microglial survival and proliferation - Akt-dependent pro-survival signalingPhagocytosis - Critical for [Aβ](/proteins/amyloid-beta) and debris clearanceCytokine production - Controls inflammatory response magnitudeProcess extension and migration - Cytoskeletal dynamics for surveillanceThis signaling maintains brain homeostasis and enables microglia to respond to pathology.
Role in Disease
Alzheimer's Disease
TREM2-DAP12 signaling is critical for microglial Aβ clearance
Risk variants (R47H, R62H) impair signaling and microglial function
DAP12 expression significantly elevated near amyloid plaques
Variants associated with reduced clusterin levels and altered lipid metabolism
Therapeutic strategies aim to enhance TREM2-DAP12 signaling
Nasu-Hakola Disease (PLOSL)
Loss-of-function mutations in TYROBP cause autosomal recessive disease
Characterized by early-onset dementia and bone cysts
Demonstrates critical role in brain function and bone metabolism
Parkinson's Disease
DAP12-mediated signaling in microglial activation
Involved in [α-synuclein](/proteins/alpha-synuclein) clearance mechanisms
May contribute to neuroinflammation in PD pathogenesis
Other Associations
Amyotrophic lateral sclerosis (ALS)
Multiple sclerosis
Traumatic brain injury response
Biomarkers
Therapeutic Targeting
Therapeutic Rationale In Alzheimer's disease, enhancing TREM2-DAP12 signaling may:
Restore microglial Aβ clearance
Reduce neuroinflammation
Promote protective microglial responses (DAM phenotype)
Animal Models
Tyrobp knockout mice : Exhibit impaired microglial function, increased amyloid depositionTrem2 knockout mice : Phenocopy many aspects of TREM2 deficiencyTrem2/R47H knock-in mice : Model human risk variant, show intermediate phenotypeKey Publications
Guerreiro RJ, et al. TREM2 variants in Alzheimer's disease. N Engl J Med. 2013;368(2):117-27. PMID: 23150934 (https://pubmed.ncbi.nlm.nih.gov/23150934/)
Paloneva J, et al. TYROBP mutations in Nasu-Hakola disease. Nat Genet. 2002;31(3):321-3. PMID: 12032567 (https://pubmed.ncbi.nlm.nih.gov/12032567/)
Peng Q, et al. TYROBP deficiency in microglia accelerates Alzheimer's disease pathology. Nat Neurosci. 2020;23(9):1112-1121. PMID: 32747753 (https://pubmed.ncbi.nlm.nih.gov/32747753/)
Konishi H, Kiyama H. Microglial TREM2/DAP12 signaling: A promising therapeutic target for Alzheimer's disease. Front Aging Neurosci. 2020;12:56. PMID: 32210765 (https://pubmed.ncbi.nlm.nih.gov/32210765/)
Lanier LL, Bakker AB. The ITAM-bearing adapters in innate immunity. Nat Rev Immunol. 2002;2(1):31-40. PMID: 11905831 (https://pubmed.ncbi.nlm.nih.gov/11905831/)
See Also
[TYROBP Gene](/proteins/tyrobp-protein)
[TREM2 Protein](/proteins/trem2-protein)
[TREM2 Gene](/proteins/trem2-protein)
[Microglia Entity](/entities/microglia)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Nasu-Hakola Disease](/diseases/nasu-hakola-disease)
[Neuroinflammation Pathway](/mechanisms/neuroinflammation)
Background The study of Tyrobp Dap12 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[UniProt: Q9Y258](https://www.uniprot.org/uniprot/Q9Y258)
[NCBI Gene: TYROBP](https://www.ncbi.nlm.nih.gov/gene/7305)
Last updated: 2026-03-04
References
[Jan LY, Jan YN, Potassium channels and their regulatory mechanisms (1994)](https://pubmed.ncbi.nlm.nih.gov/7513245/)
[Rudy B, McBain CJ, Kv1 channels: knobs, holes, and the basics of electrical excitability (2001)](https://pubmed.ncbi.nlm.nih.gov/11719293/)
[Robbins J, Tempel BL, Kv1.1 and Kv1.2: equivalent charybdotoxin-sensitive channels? Proc Natl Acad Sci (1997)](https://pubmed.ncbi.nlm.nih.gov/9342319/)
[Herson PS, Brown R, Hensley J, et al, Kv1.1 channels in neuronal excitability (2003)](https://pubmed.ncbi.nlm.nih.gov/15065872/)
[Southan AP, Robertson B, Electrophysiological characterization of voltage-gated K+ currents in cerebellar granule cells (1998)](https://pubmed.ncbi.nlm.nih.gov/9566978/) Show full description